The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Inhibition of diabetic nephropathy by a decoy peptide corresponding to the “handle” region for nonproteolytic activation of prorenin
Open accessAbstract
We found that when a site-specific binding protein interacts with the "handle" region of the prorenin prosegment, the prorenin molecule undergoes a conformational change to its enzymatically active state. This nonproteolytic activation is completely blocked by a decoy peptide with the handle region structure, which competitively binds to such a binding protein. Given increased plasma prorenin in diabetes, we examined the hypothesis that the nonproteolytic activation of prorenin plays a significant role in diabetic organ damage. Streptozotocin-induced diabetic rats were treated with subcutaneous administration of handle region peptide. Metabolic and renal histological changes and the renin-Ang system components in the plasma and kidneys were determined at 8, 16, and 24 weeks following streptozotocin treatment. Kidneys of diabetic rats contained increased Ang I and II without any changes in renin, Ang-converting enzyme, or angiotensinogen synthesis. Treatment with the handle region peptide decreased the renal content of Ang I and II, however, and completely inhibited the development of diabetic nephropathy without affecting hyperglycemia. We propose that the nonproteolytic activation of prorenin may be a significant mechanism of diabetic nephropathy. The mechanism and substances causing nonproteolytic activation of prorenin may serve as important therapeutic targets for the prevention of diabetic organ damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Nguyen, G., Delarue, F., Burcklé, C., Bouzhir-Sima, L., Giller, T., & Sraer, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14276 · Cited by 1,276
Nguyen, G., Delarue, F., Burcklé, C., Bouzhir, L., Giller, T., & Sraer, J.-D. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214276 · Cited by 1,137
Brenner, B. M., Cooper, M. E., & de Zeeuw, D. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00549-9 · Cited by 508
Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: Effects of ACEI and ARB
Onozato, M. L., Tojo, A., Goto, A., Fujita, T., & Wilcox, C. S. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00123.x · Cited by 373
Increased Plasma Inactive Renin in Diabetes Mellitus: A Marker of Microvascular Complications
Luetscher, J. A., Kraemer, F. B., Wilson, D. M., Schwartz, H. C., & Bryer-Ash, M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198505303122202 · Cited by 335
Kalluri, R., Shield, C. F., Todd, P., Hudson, B. G., & Neilson, E. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119431 · Cited by 319
Anderson, S., Jung, F. F., & Ingelfinger, J. R. (1993) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1993.265.4.f477 · Cited by 307
Human Prorenin Has “Gate and Handle” Regions for Its Non-proteolytic Activation
Suzuki, F., Hayakawa, M., Nakagawa, T., Nasir, U. M., Ebihara, A., Iwasawa, A., Ishida, Y., Nakamura, Y., & Murakami, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302579200 · Cited by 185
Self-citationVéniant, M., Ménard, J., Bruneval, P., Morley, S., Gonzales, M. F., & Mullins, J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119000 · Cited by 174
Role of growth hormone in the development of experimental renal scarring
Nahas, A. M. E., Bassett, A. H., Cope, G. H., & Carpentier, J. E. L. (1991) · Kidney International · doi:10.1038/ki.1991.175 · Cited by 155
Lewis, E. J., Hunsicker, L. G., & al, W. R. C. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00550-5 · Cited by 151
Enalapril Attenuates Oxidative Stress in Diabetic Rats
de Cavanagh, E. M. V., Inserra, F., Toblli, J. E., Stella, I., Fraga, C. G., & Ferder, L. (2001) · Hypertension · doi:10.1161/hy1101.092845 · Cited by 149
Deinum, J., Rønn, B. B., Mathiesen, E. R., Derkx, F. H. M., Hop, W. C. J., & Schalekamp, M. A. D. H. (1999) · Diabetologia · doi:10.1007/s001250051260 · Cited by 145
Mannose 6-Phosphate Receptor–Mediated Internalization and Activation of Prorenin by Cardiac Cells
van Kesteren, C. A. M., Danser, A. H. J., Derkx, F. H. M., Dekkers, D. H. W., Lamers, J. M. J., Saxena, P. R., & Schalekamp, M. A. D. H. (1997) · Hypertension · doi:10.1161/01.hyp.30.6.1389 · Cited by 142
Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat
Zimpelmann, J., Kumar, D., Levine, D. Z., Wehbi, G. J., Imig, J. D., Navar, L. G., & Burns, K. D. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00416.x · Cited by 133
Functional Significance of Prorenin Internalization in the Rat Heart
Peters, J., Farrenkopf, R., Clausmeyer, S., Zimmer, J., Kantachuvesiri, S., Sharp, M. G. F., & Mullins, J. J. (2002) · Circulation Research · doi:10.1161/01.res.0000019242.51541.99 · Cited by 120
Zhang, S., Filep, J. G., Hohman, T. C., Tang, S., Ingelfinger, J. R., & Chan, J. S. D. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00271.x · Cited by 118
Maru, I., Ohta, Y., Murata, K., & Tsukada, Y. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.27.16294 · Cited by 114
Nishiyama, A., Seth, D. M., & Navar, L. G. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000026610.48842.cb · Cited by 103
Self-citationAugmented Diurnal Variations of the Cardiac Renin-Angiotensin System in Hypertensive Rats
Naito, Y., Tsujino, T., Fujioka, Y., Ohyanagi, M., & Iwasaki, T. (2002) · Hypertension · doi:10.1161/01.hyp.0000039960.66987.89 · Cited by 96
Renal hemodynamics and plasma and kidney angiotensin II in established diabetes mellitus in rats
Vallon, V., Wead, L. M., & Blantz, R. C. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v5101761 · Cited by 86
Decreased Degradative Enzymes in Mesangial Cells Cultured in High Glucose Media
Leehey, D. J., Song, R. H., Alavi, N., & Singh, A. K. (1995) · Diabetes · doi:10.2337/diab.44.8.929 · Cited by 74
Renin Is Expressed in Rat Macrophage/Monocyte Cells
Iwai, N., Inagami, T., Ohmichi, N., & Kinoshita, M. (1996) · Hypertension · doi:10.1161/01.hyp.27.3.399 · Cited by 71
Self-citationUptake and proteolytic activation of prorenin by cultured human endothelial cells
Admiraal, P. J. J., van Kesteren, C. A. M., Danser, A. H. J., Derkx, F. H. M., Sluiter, W. J., & Schalekamp, M. A. D. H. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917050-00005 · Cited by 67
Choi, K. C., Nh, K., Mr, A., Kang, D. G., Sw, K., & Lee, J. (1997) · PubMed · Cited by 63
Thyroid hormone stimulates renin synthesis in rats without involving the sympathetic nervous system
Kobori, H., Ichihara, A., Suzuki, H., Miyashita, Y., Hayashi, M., & Saruta, T. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.272.2.e227 · Cited by 57
Self-citationCampbell, D. J., Kelly, D. J., Wilkinson‐Berka, J. L., Cooper, M. E., & Skinner, S. L. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00519.x · Cited by 55
The renin-angiotensin system in streptozotocin-induced diabetes mellitus in the rat.
Kalinyak, J. E., Sechi, L. A., Griffin, C. A., Don, B. R., Tavangar, K., Kraemer, F. B., Hoffman, A. R., & Schambelan, M. (1993) · Journal of the American Society of Nephrology · doi:10.1681/asn.v461337 · Cited by 54
Enhanced renal sensitivity to angiotensin actions in diabetes mellitus in the rat
Kennefick, T. M., Oyama, T. T., Thompson, M. M., et al. (1996) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1996.271.3.f595 · Cited by 33
Wassélius, J., Wallin, H., Abrahamson, M., & Ehinger, B. (2003) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-003-0782-x · Cited by 28
Copper deficiency increases hepatic apolipoprotein B secretion and mRNA editing in rats
Reaves, S. K., Hoogeveen, R. C., Wang, Y. R., Wu, J., & Lei, K. Y. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.2.c595 · Cited by 28
Hirota, N., Ichihara, A., Koura, Y., Hayashi, M., & Saruta, T. (2002) · Hypertension · doi:10.1161/hy02t2.102807 · Cited by 11
Self-citation
Cited by
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
Physiology of Local Renin-Angiotensin Systems
Paul, M., Poyan Mehr, A., & Kreutz, R. (2006) · Physiological Reviews · doi:10.1152/physrev.00036.2005 · Cited by 1,739
Kobori, H., Nangaku, M., Navar, L. G., & Nishiyama, A. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.3.3 · Cited by 1,237
Self-citationThe Renin-Angiotensin Aldosterone System: Pathophysiological Role and Pharmacologic Inhibition
Atlas, S. A. (2007) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2007.13.s8-b.9 · Cited by 722
Renin‐angiotensin system revisited
Fyhrquist, F., & Saijonmaa, O. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01981.x · Cited by 642
Metadata
- Authors
- Ichihara, A., Hayashi, M., Kaneshiro, Y., Suzuki, F., Nakagawa, T., Tada, Y., Koura, Y., Nishiyama, A., Okada, H., Uddin, M. N., Nabi, A. H. M. N., Ishida, Y., Inagami, T., & Saruta, T.
- Venue
- Journal of Clinical Investigation
- Published
- 2004-10-15
- Volume
- 114
- Issue
- 8
- Pages
- 1128-1135
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2146227799
- Cited by
- 456
- References
- 35
- FWCI
- 13.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.